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Abstract
Background: Placental malaria is typified by selective clustering of Plasmodium falciparum in the intervillous blood
spaces of the placenta. Sequestration of malaria parasite in the human placenta is mediated by interactions
between chondroitin sulphate A (CSA) on the syncytiotrophoblasts and proteins expressed on the surface of
infected human erythrocytes. Plasmodium falciparum Erythrocyte Membrane Protein 1 (PfEMP1) encoded by the
var2CSA gene is believed to be the main parasite ligand for CSA-mediated placental binding.
Methods: Extensive sequence and structure comparisons of the various CSA-binding and non-binding DBL
domains from the var2CSA gene from A4 and 3D7 strains of P. falciparum were performed. Three-dimensional
structural models of various DBL domains were built and analysed with a view to assessing conservation of CSA
interaction sites across various DBL domains.
Results: Each of the six DBL domains from var2CSA are likely to retain the disulfide linkages evident from
previously published DBL domain crystal structures. The number of disulfide linkages between the various DBL
domains analysed varies from three to seven, of which two are conserved across all DBL domains. The conserved
disulfide linkages are distributed within the respective three sub-domains and only one linkage is shared by sub-
domains I and II. Major differences between CSA-binding DBL domains are in the loop regions, which tie the alpha
helices together, and in variable length terminal extensions. Intriguingly, a crucial loop from A4 DBL 3X which
provides the important Gly and Lys residues that chelate the bound sulphate is missing or significantly altered in
all other DBL domains that interact with CSA. Further analysis of the proposed sulphate and predicted CSA-
binding site indicates either none or very low level of conservation among the critical interacting residues.
Conclusion: Structural comparisons of the three-dimensional structures of CSA-binding DBL domains indicates
that the proposed CSA interaction site on A4 DBL 3X is unlikely to be conserved across the other CSA-binding
DBL domains from var2CSA. Therefore, the 4 CSA-binding DBL domains encoded by var2CSA are unlikely to have
common architectures to their CSA recognition sites. These structural insights have clear implications in using
CSA-binding DBL domains for vaccines against placental malaria as it is proposed that the various CSA-binding
DBL domains on var2CSA will recognize their CSA ligands differently.
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Background
It has long been observed that there is an increase in the
severity of malaria during pregnancy, resulting in such
negative outcomes as maternal anaemia and reduction in
birth weight, which in turn lead to increase in maternal
and infant mortality [1]. Adverse outcomes of pregnancy-
associated malaria (PAM) include low birth weight
neonates, foetal loss, increased perinatal and maternal
mortality, maternal anaemia and the risk of hypertension
in first-time pregnant mothers [2].
Pregnancy-associated malaria is coupled with massive
accumulation of parasitized erythrocytes (PE) and mono-
cytes in the placental intervillous blood spaces. The basis
for the amassing of parasitized erythrocytes (PEs) in the
placenta was unknown until it was shown that PEs from
placenta primarily bind to chondroitin sulfate A (CSA)
[3]. Significantly, after one or two pregnancies, antibodies
that recognize placental PEs from different geographic
regions develop and correlate with protection against
PAM [3,4]. Antibodies against CSA-binding parasites that
develop in multigravidae in endemic areas also block
CSA-binding of placental isolates from different parts of
the world, demonstrating the development of strain tran-
scending antibodies to the Plasmodium falciparum ligands
that mediate adhesion to CSA [5].
The var2CSA gene, which is a member of the P. falciparum
Erythrocyte Membrane Protein 1 (PfEMP1) family, may
have an important role in PAM disease and immunity.
This gene encodes a large protein with an estimated
molecular weight of 350 kDa, and can be divided into six
Duffy-binding-like domains (DBL 1–6) based on several
conserved cysteines. The DBL domains are cysteine-rich
modules which recognize diverse host cell-surface recep-
tors during pathogenesis. The gene var2CSA is found in all
parasite isolates and is transcriptionally up-regulated in
both placental isolates and laboratory parasites selected to
bind CSA [6-9]. Significantly, var2CSA knock-out para-
sites revealed that no other parasite ligand can promote
adhesion to CSA [6]. Furthermore, the var2CSA encoded
protein contains multiple CSA-binding DBL domains and
is the target of maternal antibodies, making it the leading
candidate for malaria vaccine in pregnancy. [7-9].
In the present study, three-dimensional structures of all
CSA-binding and non-binding DBL domains from A4 and
3D7 strains of P. falciparum were modelled and analysed
by predicting the disulfide linkages using the crystal struc-
tures of A4 DBL 3X domain , Plasmodium knowlesi DBL
domain Pkα-DBL and P. falciparum EBA-175 DBL
domains F1 and F2 [10-13]. An overall comparison based
upon the superposition of these domains shows that sec-
ondary structure elements are conserved and major differ-
ences between the various domains lie mainly within
flexible loop regions and/or N/C termini. The number of
disulfide linkages between various DBL domains analysed
varies from three to seven, of which two are conserved
across all domains. Intriguingly, the surface charge prop-
erties of each of these analysed DBL domains clearly indi-
cate that there are no conserved patches of either positive
or negative charge density. Further, none of these DBL
domains harbour exposed hydrophobic patch of reasona-
ble volume. A comparison of the proposed CSA-binding
site (based upon the sulphate ion bound in A4 DBL 3X
crystal structures [10,11]) shows that this binding site is
unlikely to be conserved among different CSA-binding
domains. The structural analysis and structure-based
insights presented here have widespread implications in
using CSA-binding DBL domains for vaccines against pla-
cental malaria.
Methods
Sequence alignments and structural modelling of var2CSA 
gene DBL domains
All sequence alignments were done using ClustalW2
online program. Structures of the DBL domains from A4
and 3D7 var2CSA were modelled using HHpred server
with default settings [14]. The HHpred method is based
on comparisons and alignments of hidden Markov mod-
els (HMMs), which include gaps and insertion probabili-
ties [14]. The var2CSA DBL domains were modelled for
3D7 (PFL0030c, Plasmodium  genomic database 'Plas-
moDB') and for A4 strains (accession code AY372123).
The PFL0030c sequence was split into separate domains
(DBL 1X aa 46–343, DBL 2X aa 535–921, DBL 3X aa
1209–1559, DBL 4ε aa 1560–1982, DBL 5ε aa 1983–
2079 and DBL 6ε aa 2323–2628). The A4 accession code
AY372123 sequence was also split into separate domains
(DBL 1X aa 46–344, DBL 2X aa 536–930, DBL 4ε aa
1578–1988, DBL 5ε aa 1989–2276 and DBL 6ε aa 2320–
2631). All HMM databases available in web-server were
used for template structure search, including the Protein
Data Bank. Multi-template alignments proposed by the
HHpred method were used to generate 3D models by
using HHpred server toolkit protocol for MODELLER
[15]. Structure superpositions were done using Match-
Maker in Chimera [16]. All structural visualizations were
produced using Chimera.
Results and discussion
Sequence alignments of var2CSA DBL domains
The crystal structures of DBL 3X domain from A4 strain of
P. falciparum have been recently determined with a single
bound sulphate ion [10,11]. The protein sequences of all
var2CSA encoded DBL domains from the A4 and 3D7
strains of P. falciparum (2X, 3X, 5ε and 6ε) that bind CSA
and also two remaining non CSA-binding domains (1X
and 4ε) were aligned with the A4 DBL 3X crystal structure
sequence. Since all conserved cysteines in DBL domains
where structures have been determined to date [10-13]
make conserved disulfide linkages with other cysteines,Malaria Journal 2009, 8:67 http://www.malariajournal.com/content/8/1/67
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this strongly suggests that DBL domains are constructed
around conserved structural features like these S-S link-
ages. Therefore, in the sequence analysis of CSA-binding
and non-binding DBL domains (with reference to the
crystal structure of A4 DBL 3X), this structural property of
DBL domains was utilized for generating sequence align-
ments and for defining the domain boundaries. After
aligning the sequences, disulphide linkages in the struc-
ture of A4 DBL 3X were compared with sequences of 3D7
DBL 3X domain (Additional file 1) and with other 3D7
var2CSA DBL domains. Subsequently, predictions were
made for the disulfide linkages of all DBL domains from
A4 and 3D7. Based upon these predictions, final sequence
boundaries for DBL domains were defined (Additional
file 2). These sequence boundaries were then utilized for
homology modelling of all var2CSA domains that bind
CSA using the recently determined crystal structures of A4
DBL 3X and previously determined structures of P. knowl-
esi DBL domain Pkα-DBL and P. falciparum EBA-175 DBL
domains F1 and F2 [10-13]. Sequence boundaries for the
non CSA-binding DBL 1X and 4ε domains from 3D7 and
A4 var2CSA respectively were also defined using a similar
procedure. For the DBL 4ε domain, sequence boundary
was defined as the entire sequence between DBL 3X and
5ε domains in var2CSA (Figure 1). These sequence bound-
aries were used for structural modelling of the CSA-bind-
ing and non-binding DBL domains (Figure 1).
Structural modelling of the var2CSA DBL domains
Overall sequence identity between CSA-binding DBL
domains of different sub-types from A4 var2CSA and 3D7
var2CSA is low (ranges from 13 to 28%) (Table 1). In con-
trast, the sequence identity between CSA-binding DBL
domains of same sub-type is high (from 62 to 87%)
(Table 1). After sequence boundaries had been defined for
all CSA-binding and non-binding domains (Figure 1,
Additional file 2), 3D structures of these 3D7 and A4 DBL
domains were modelled. The template search in HHpred
listed the recently determined structure of P. falciparum A4
DBL 3X [10], P. knowlesi DBL domain Pkα-DBL [12] and
P. falciparum EBA-175 DBL domains F1 and F2 [13]. Uti-
lizing all these templates, multi-template models of a total
of seven CSA-binding domains (3D7 var2CSA DBL 2X,
3X, 5ε and 6ε domains; A4 var2CSA DBL 2X, 5ε and 6ε
domains) and two non-binding domains (3D7 var2CSA
DBL 1X and A4 var2CSA DBL 4ε) were generated. The
structures for DBL domains 3D7 DBL 1X and 3X; A4 and
3D7 DBL 5ε and A4 and 3D7 DBL 6ε were modelled suc-
cessfully in the first run. However, for 3D7 and A4 DBL 2X
domains, the program inserted a loop region in the mid-
dle of a crucial and conserved α-helix 2 in sub-domain II
– a result which is unlikely. Hence, to successfully gener-
ate correct models for 2X domain, the input sequence
length for the program was altered while keeping con-
served disulfides intact in this altered 2X sequence length
(Figure 1). Models for non-binding DBL 1X and 4ε
domains were used as controls for comparative structural
analysis of CSA-binding DBL domains. Since the entire
sequence length between DBL 3X and 5ε domains was
used to model DBL 4ε domain, it was observed that the N-
and C- terminal regions of DBL 4ε are longer and flexible
when compared to other DBL domains.
Domain diagram of A4 var2CSA gene Figure 1
Domain diagram of A4 var2CSA gene. Distribution of residues that form various DBL domains is shown. Modelled struc-
tures for the corresponding domains are given below each domain box. All models are shown in surface representation and 
coloured yellow. The sulphate-binding residues on A4 DBL 3X crystal structure are coloured blue (PDB codes: 3BQK and 
3CPZ).Malaria Journal 2009, 8:67 http://www.malariajournal.com/content/8/1/67
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Structural superpositions of the seven domains that bind
CSA and the two non-binding domains were performed
on to the A4 DBL 3X crystal structure (10; PDB code:
3BQK) (Figure 2a, b). A structure-based sequence align-
ment was subsequently generated keeping the A4 DBL 3X
crystal secondary structure as a control (Additional file 4).
The disulfide linkage predictions made earlier on the basis
of sequence alignments with the A4 DBL 3X crystal struc-
ture were confirmed upon generation of these models
(Table 2).
Structural comparisons between CSA-binding DBL 
domains
All the modelled domain structures contain sub-domains
I, II and III similar to the crystal structures of P. falciparum
A4 DBL 3X, P. falciparum EBA-175 DBL domains F1 and
F2 and P. knowlesi DBL domain Pkα-DBL [10-13] as has
been shown earlier [17]. Further, the overall alpha-helical
content in sub-domains II and III is conserved in all mod-
elled DBL domains. Structural differences lie mostly in
loop regions between helices and/or in the N- and/or C-
termini which are flexible and could assume variable ori-
entations. Sub-domain I contains an N-terminal region of
variable residue length which is highly flexible. In sub-
domain II, the loop regions/random coils between α-hel-
ices 1 and 2 and α-helices 3 and 4 are longer in the DBL
3X and 2X domains respectively when compared to the
other domains. The C-terminal region is also compara-
tively longer for A4 and 3D7 DBL 2X domains mainly
because the A4 DBL 2X domain has larger number of res-
idues in A4 (395 aa). These extra residues in DBL 2X
domains are mostly inserted in flexible loops regions
between the helices in sub-domains II and III and/or in C-
terminal regions. The DBL 4ε domain consists of 411 res-
idues and possesses comparatively longer termini that are
probably flexible in nature. The regions which have not
been modelled for var2CSA  domains are the non-DBL
domain stretches from A4 at the start (aa 1–45), between
DBL 1X and 2X (aa 345–535), between 2X and 3X (aa
931–1217), between 5ε and 6ε domains (aa 2277–2322)
and in the TM/ATS region (aa 2632–3064) (Figure 1).
The DBL domains of A4 and 3D7 var2CSA have three to
seven conserved disulfide linkages (Table 2). Upon ana-
lysing distribution of these disulfide linkages in various
sub-domains, it was noted that sub-domains I and II each
contain two and one conserved linkages respectively
(based on the A4 DBL 3X crystal structure) while sub-
domain III contains three conserved and three predicted
linkages (based on structural modelling) (Additional file
4, Figure 3). There is only one conserved inter-domain
disulfide bond which links sub-domains I and II, whereas
all other disulfide bonds are intra sub-domain linkages
(Additional file 4, Figure 3, 4) [12,13]. In sub-domain I,
both the conserved disulfide linkages occur in loop
regions. In sub-domain II, the conserved disulfide links α-
helix 2 and a loop region. Overall, there are two disulfide
linkages that are conserved in all the CSA-binding DBL
domains and these lie in sub-domain III (Additional file
4, Figure 3).
A consideration of the sulphate binding site from A4 DBL 
3X crystal structures
In the crystal structure of A4 DBL 3X (10; PDB code:
3BQK; Figure 5a, b), a single sulphate ion is bound in a
pocket located between a loop at a turn between α-helices
1 and 2 of sub-domain II and makes contact with a resi-
due from α-helix 1 of sub-domain III. This proposed bind-
ing site contains two charged basic residues (Lys1324 and
Arg1467) and a Gly1329 which together interact with the
sulphate ion. Lys1324 and Gly1329 lie in the loop
whereas Arg1467 lies towards the end of α-helix 1 of sub-
domain III. Lys1324 forms hydrogen bonds with Arg
1467 and enables Gly1329 to interact with the sulfate ion
[10]. These residues from the crystal structure were com-
pared with the corresponding residues from the other
CSA-binding DBL domains (Table 3). The α-helix which
contains residue Arg1467 shows poor sequence conserva-
tion amongst CSA-binding domains except in A4 DBL 6ε.
Replacement of an Arg/Lys residue by a Gln may retain the
ability to form a hydrogen bond with the sulphate ion,
but without the electrostatic component in the binding
Table 1: Sequence identity within the var2CSA DBL domains 
from 3D7 and A4 (in percentage)
CSA-binding domains Non binders
3D7 A4 3D7 A4
2X 3X 5ε 6ε 2X 3X 5ε 6ε 1X 4ε
3D7 2X -
3D7 3X 23 -
3D7 5ε 21 17 -
3D7 6ε 21 18 28 -
A4 2X 80 19 23 21 -
A4 3X 24 85 17 16 18 -
A4 5ε 24 18 87 27 27 17 -
A4 6ε 22 19 25 62 18 16 24 -
3D7 1X 23 20 18 16 26 20 23 18 -
A4 4ε 17 16 21 26 13 16 24 23 19 -Malaria Journal 2009, 8:67 http://www.malariajournal.com/content/8/1/67
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interface. Further, Arg1467 is replaced by Gln in 3D7 DBL
3X, which displays high sequence similarity with the A4
DBL 3X. Interestingly, this Arg1467 is replaced by Glu res-
idue in 3D7 DBL 2X, 5ε, 6ε and A4 DBL 5ε – conferring an
opposite charge to this important residue. Furthermore, in
3D7 DBL 2X and 1X domains there is replacement by Ala
and Asn residues respectively (Table 3). The other two res-
idues involved in binding to sulphate, Lys1324 and
Gly1329, are present in the loop region between the α-
helices 1 and 2 of sub-domain II (Figure 6a, b). In 3D7
DBL 3X domain, the corresponding Arg and Gly residues
are present thus indicating that the mode of sulphate
binding is, not surprisingly (just a difference in parasite
strains), likely to be conserved in the DBL 3X domains, as
has been earlier suggested [10]. However for the other
domains, this region is highly flexible and the corre-
sponding residues for Lys and Gly are absent in the
sequence/structural alignment of these domains (Figure
6a, b).
Another crystal structure of the A4 DBL 3X with a single
sulfate ion bound has been determined recently [[11];
PDB code: 3CPZ]. However, in this second structure, the
residue environment is absent for the sulphate ion and
upon the superposition of the 2 crystal structures of A4
DBL 3X, the position of the sulphur atom differs by a dis-
tance of ~3.6 Å (Figure 5a, b). Further, one additional res-
idue – Lys1540 – is implicated in making contact with the
Analysis/comparison of CSA-binding and non-binding DBL domains with A4 DBL 3X (PDB code: 2BQK) Figure 2
Analysis/comparison of CSA-binding and non-binding DBL domains with A4 DBL 3X (PDB code: 2BQK). (a) 
Superposition of CSA-binding A4 DBL 2X, 5ε, 6ε domains and 3D7 DBL 2X, 3X, 5ε and 6ε domains onto A4 DBL 3X struc-
ture. (b) Superposition of non-CSA-binding DBL domains 3D7 DBL 1X and A4 DBL 4ε on to A4 DBL 3X structure.Malaria Journal 2009, 8:67 http://www.malariajournal.com/content/8/1/67
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sulphate ion. Apart from this residue, four other residues
(Lys1327, Arg1503, Lys1507 and Lys 1510) have been
highlighted which all are at a distance of ~5Å from the
modelled CSA in the crystal structure [11]. The corre-
sponding residues implicated in binding to modelled CSA
[11] were further analysed in all CSA-binding domains
(Table 3). The corresponding residues for the non-bind-
ing DBL 1X and 4ε domains were also highlighted. From
this comparison, it is again evident that the site where the
sulphate ion binds [11] is not conserved amongst the
CSA-binding DBL domains (Table 3). The residue
Lys1504 (though it does not make any contact with the
sulphate ion; PDB code: 3CPZ) has a corresponding Lys in
3D7 DBL 3X, 2X and the non-binding DBL 1X domains
(Table 3). However, it is replaced by Glu or Ala in other
CSA-binding DBL domains. The other four residues impli-
cated in CSA binding (at interacting distance of ~5Å dis-
tance) are also not conserved in these domains (Table 3).
These sulphate binding residues were also compared with
the corresponding ones in DBL 3γ domain of var1CSA
which binds CSA [9]. The proposed binding site is, once
Table 2: Disulfide linkages in CSA-binding DBL domains
Strain and DBL domain Disulfide linkages based on A4 DBL 3X Additional predicted disulfides Likely free cystein(s)
A4 3X crystal structure 8 - None
1 3D7 3X 7 - 2 (C1212, C1558)
2 3D7 2X 4 C793 and C920 10 
(C540, C543, C592, C732, C733, C786, 
C797, C815, C855, C901)
3 A4 2X 3 C795 and C910
C817 and C877
9 
(C544, C547, C599, C617, C734, C788, 
C799, C807, C929)
43 D 7  5 ε 3 C2004 and C2041 2 (C1995, C2165)
5A 4  5 ε 3 C2010 and C2047 2 (C2001, C2171)
63 D 7  6 ε 3- 7  
(C2334, C2385, C2480, C2539, C2602, 
C2604, C2625)
7A 4  6 ε 3- 8  
(C2331, C2383, C2478, C2493, C2535, 
C2597, C2599, C2628)
Distribution of disulfide linkages amongst the 3 sub-domains Figure 3
Distribution of disulfide linkages amongst the 3 sub-
domains. Sub-domain I, II and III each contain 2, 1 and 3 
conserved disulfide linkages respectively (shown as lines). 
The 2 disulfides in sub-domain III (coloured red) are con-
served in all CSA-binding DBL domains.
Inter and intra-domain disulfide linkages in DBL domains Figure 4
Inter and intra-domain disulfide linkages in DBL 
domains. For all DBL domains, only sub-domain I and II 
share 1 inter-domain disulfide linkage whereas there are no 
inter-domain linkages between sub-domains I and III and sub-
domains II and III.Malaria Journal 2009, 8:67 http://www.malariajournal.com/content/8/1/67
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again, not conserved in DBL 3γ although all the three
disulfide linkages predicted for DBL 3γ domain are in
accordance with the A4 DBL 3X crystal structure.
Thus, comparison of the sulphate binding residues (from
the two crystal structures) in these DBL domains shows
that the sulphate binding site is only very partially con-
served in the seven CSA-binding DBL domains from
var2CSA (Figure 6, 7; Table 3) and in one DBL domain
from var1CSA. Interestingly, few of these residues are con-
served in DBL 1X and 4ε domains which do not bind CSA
(Figure 7; Table 3). This lack of conservation in the sul-
phate binding site is also evident from the low sequence
identity shared by these DBL domains (Table 1). Thus, it
is unclear whether the crystal structure-based sulphate ion
binding sites will interact with sulphate from CSA in a
similar manner in other DBL domains. Since the pro-
posed sites only bind a single sulphate ion in current crys-
tal structures, it may be too early to speculate whether this
is strictly the region which can be defined as the CSA rec-
ognition site in other CSA-binding DBL domains.
Conservation in the CSA-binding sites within all four DBL
domains of a given var2CSA gene is intuitively, and from
the presented data evidentially, unfeasible and unlikely.
Instead, it is likely that CSA-binding DBL domains have
evolved to differ in their regions which recognize CSA – a
notable feature of significance if the parasite needs to
evade immune responses efficiently. As an extension of
this argument, it is proposed that it may be unlikely that
a common inhibitor/drug will bind to the CSA-recogni-
tion pocket in all CSA-recognizing DBL domains. In sum-
mary, it is plausible that CSA makes different (potentially
Superposition of A4 DBL 3X crystal structures (PDB codes: 2BQK and 3CPZ) Figure 5
Superposition of A4 DBL 3X crystal structures (PDB codes: 2BQK and 3CPZ). (a) Superposition shown in surface 
representation. The A4 DBL 3X crystal structures are coloured brown (PDB code: 3BQK) and blue (PDB code: 3CPZ. (b) 
Close view of the sulphate-binding site. The sulphate ions bound to the structures are labelled S1 (green; PDB code: 2BQK) 
and S2 (red; PDB code: 3CPZ) respectively. S1 makes contacts with residues Lys1324, Gly1329 and Arg1467. The sulphate ion 
S2 however does not make protein residue contacts and the distance of its sulphur atom from the sulphur atom of S1 is ~3.6Å.
Comparison of sulphate binding site in all the CSA-binding  var2CSA DBL domains Figure 6
Comparison of sulphate binding site in all the CSA-
binding var2CSA DBL domains. (a) Superposition of all 
CSA-binding DBL domains onto the A4 DBL 3X crystal 
structure (PDB code: 3BQK). The sulphate-binding site is 
highlighted. (b) Close view of the sulphate-binding site. The 
loop region bearing the important Gly and Lys residues is 
magnified. This loop is either absent or is in a different orien-
tation in all CSA-binding domains except A4 (magenta) and 
3D7 (green) DBL 3X.Malaria Journal 2009, 8:67 http://www.malariajournal.com/content/8/1/67
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Table 3: Comparison of residues implicated in sulphate binding
CSA-binding DBL domains Non-binders
A4 3X 3D7 3X 2X 5ε 6ε A4 4ε 3D7 1X
A4 3D7 A4 3D7 A4 3D7
Sulfate binding residues
K 1324* R- -- -- -H -
G 1329* G- - K -- -- -
R1467* Q A E E E K E KN
K1504 # K E K E E A A A K
Residues within 5Å of modelled CSA
K1327# M - K- K-- -
R1503# R D N S S H E K D
K1507# E KV KK NN N K
K1510# KK K E E N N N E
￿ [10,11].
￿ Conserved residues are in bold, acidic residues are in italics and underlined and other residues are bold and underlined.
Comparison of sulphate-binding residues in var2CSA DBL domains. Figure 7
Comparison of sulphate-binding residues in var2CSA DBL domains. A4 DBL 3X crystal structure is used as control 
and all residues involved in binding to sulphate ion are coloured blue (PDB codes: 3BQK and 3CPZ). Residues which are con-
served in other domains are also colored blue. Residues which are replaced with acidic amino acids are coloured red. Residues 
replaced by other residue types are coloured cyan.Malaria Journal 2009, 8:67 http://www.malariajournal.com/content/8/1/67
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non-overlapping) binding footprints on various CSA-
binding DBL domains.
Analysis of conserved regions on CSA-binding DBL domains
To investigate if there are other regions on these DBL
domains which have identical/conserved and exposed resi-
dues, the surfaces of DBL domains were inspected (keeping
in view sequence and structural information from crystal
structure of A4 DBL 3X [10]). These residues were then
highlighted amongst the DBL domains based on the
described criterion (Additional file 3, Figure 8). Based upon
identification of identical/conserved surface residues, three
new regions are proposed on A4 DBL 3X which are con-
served between all CSA-binding DBL domains (Figure 8).
Two of these regions (named conserved region – CR1 and
CR2) are on the same face as the sulphate binding site (pro-
posed CSA-binding site) and a third region (named CR3) is
on the opposite face. The cavity formed by CR1 consists of
conserved residues Ile1265, Gln1270, Leu1272, Leu1310,
Asp1353, Met1357 and Gln1449 – which lie mostly in sub-
domain I while few lie in α-helices 1 and 2 of sub-domain
II. The region constituting CR2, which lies on the same face
as the sulphate binding site, has more hydrophilic residues
when compared to CR1, including exposed lysine residues
Lys1378 and Lys1382. The other residues constituting CR2
are Ile1358, Gly1360, Val1363 and Trp1404. These resi-
dues lie mostly between α-helices 2 and 3 of sub-domain II.
The third conserved region CR3, which is on the opposite
face of the sulphate binding site, and has a line up of resi-
dues such as Phe1351, Trp1405, Trp1413, Pro1441,
Val1451, Lys1455 and Tyr1526. The residues constituting
this region are scattered in α-helices 1, 2 and 4 of sub-
domain II and in α-helices 1 and 2 of sub-domain III. All
these three conserved regions lie only in sub-domain I and
II except for a few residues of CR3 which emanate from sub-
domain III. It is interesting to note the presence of these
conserved CR1–CR3 regions on different CSA binding DBL
domains (Figure 8). The exact relevance of these three con-
served regions is not yet clear but they may play a structural
role in these DBL domains. If so, these sites may be poten-
tial new targets for development of small molecules that
target the overall functioning of DBL domains.
In an earlier study, antibody binding regions have been
predicted on DBL domains by identifying linear epitopes
and mapping them onto the modelled DBL structures
[17]. For the CSA-binding DBL 2X, 3X, 5ε and 6ε
domains, the epitope regions lie exclusively in sub-
domain I and II [17]. Interestingly, for DBL 4ε, which does
not bind CSA, the epitope region also covers the sub-
domain III. The proposed CSA-binding site lies mostly in
sub-domain III [10,11]. The identified regions CR1 and
CR2 are only in sub-domain I and II and only a few resi-
dues from the CR3 lie in sub-domain III. Also, few resi-
dues of conserved regions CR1 and CR2 that lie
exclusively in sub-domain I and II are in proximity and/or
overlap with this proposed antibody binding region [17].
Whether such conserved B cell epitopes can serve as tar-
gets for strain-transcending antibodies directed against
these CSA-binding domains remains to be determined.
Whether any of these conserved surfaces on CSA-binding
DBL domains can serve as targets for B cell epitopes is also
unknown as yet.
Conclusion
In the present study, three-dimensional structures of CSA-
binding DBL domains from var2CSA – the main parasite
ligand for human placental CSA – were predicted and ana-
lysed. The analysed DBL domains have a variable number
of disulfide linkages out of which three to seven are con-
served in accordance with the A4 DBL 3X crystal structure.
The described detailed sequence and structural analysis
suggests that the CSA-binding DBL domains from
var2CSA and var1CSA are unlikely to retain similar/iden-
tical CSA recognition surfaces. This crucial observation
seems consistent with the need for P. falciparum to con-
stantly evade immune responses against its CSA recogniz-
ing DBL domains. Maintenance of identical CSA
interacting sites on the four DBL domains from var2CSA
will provide an easier immune target than a scenario
where the four DBL domains use different and variable
surfaces for CSA chelation. It is more evident than before
that a complete description of CSA-binding footprints on
CSA-binding DBL domains will be of tremendous value as
a platform to further guide efforts at drug/vaccine devel-
opment against placental malaria.
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